Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omer Dizdar

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
The Oncologist|April 19, 2015
Is dexamethasone a better partner for abiraterone than prednisolone?Omer Dizdar
International Journal of Cancer|November 16, 2020
Comments on "Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database"Omer Dizdar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
p53 status in locally advanced bladder cancerOmer Dizdar, Umut Demirci
JAMA Oncology|April 19, 2017
Tumor Sidedness and Prognosis in Colorectal Cancer: Is Microbiome the Missing Link?Yusuf Karakas, Omer Dizdar
Medical Hypotheses|October 19, 2004
Obesity: an endocrine tumor?Omer Dizdar, Evrim Alyamaç
Breast Cancer Research and Treatment|April 27, 2019
Classifying sarcopenia: using median value or cut-off values?Onur Bas, Omer Dizdar
Breast Cancer Research and Treatment|July 28, 2018
Glucocorticoids in breast cancer treatment: real benefit or selection bias?Gurkan Guner, Omer Dizdar
Hepato-Gastroenterology|October 26, 2011
Nilotinib in advanced gastrointestinal stromal tumors after imatinib and sunitinib therapyOmer Dizdar, Suayib Yalcin
Hepato-Gastroenterology|August 12, 2011
Nilotinib is effective in imatinib and sunitinib resistant GIST: a case reportOmer Dizdar, Suayib Yalcin
Expert Opinion on Emerging Drugs|March 13, 2009
Emerging drugs in metastatic breast cancerOmer Dizdar, Kadri Altundag
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
The Oncologist|April 19, 2015
Is dexamethasone a better partner for abiraterone than prednisolone?Omer Dizdar
International Journal of Cancer|November 16, 2020
Comments on "Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database"Omer Dizdar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
p53 status in locally advanced bladder cancerOmer Dizdar, Umut Demirci
JAMA Oncology|April 19, 2017
Tumor Sidedness and Prognosis in Colorectal Cancer: Is Microbiome the Missing Link?Yusuf Karakas, Omer Dizdar
Medical Hypotheses|October 19, 2004
Obesity: an endocrine tumor?Omer Dizdar, Evrim Alyamaç
Breast Cancer Research and Treatment|April 27, 2019
Classifying sarcopenia: using median value or cut-off values?Onur Bas, Omer Dizdar
Breast Cancer Research and Treatment|July 28, 2018
Glucocorticoids in breast cancer treatment: real benefit or selection bias?Gurkan Guner, Omer Dizdar
Hepato-Gastroenterology|October 26, 2011
Nilotinib in advanced gastrointestinal stromal tumors after imatinib and sunitinib therapyOmer Dizdar, Suayib Yalcin
Hepato-Gastroenterology|August 12, 2011
Nilotinib is effective in imatinib and sunitinib resistant GIST: a case reportOmer Dizdar, Suayib Yalcin
Expert Opinion on Emerging Drugs|March 13, 2009
Emerging drugs in metastatic breast cancerOmer Dizdar, Kadri Altundag
Pageof 17